A new hub for biotech innovation: INNEXIS is developing a pharmaceutical and life sciences park in Orth an der Donau
Quick Info

„The Orth Pharma & Life Science Park offers excellent conditions for companies in the biotechnology and pharmaceutical sectors.” "The existing infrastructure, the strong research environment and the central location in Europe make this location an ideal base for innovation and growth.“
What makes Austria so attractive to companies like INNEXIS?
Austria has a strong life sciences ecosystem and is one of Europe’s leading centres of innovation. The Greater Vienna area, in particular, brings together universities, research institutes and international companies within a closely networked environment. For companies in the pharmaceutical and biotechnology sectors, the region offers a stable regulatory framework, internationally recognised GMP standards and access to the European pharmaceutical market. In addition to the regulatory framework, economic support schemes and investment incentives also help to encourage innovative industrial development and provide planning certainty for international companies. At the same time, companies benefit from a well-educated, international talent pool and an excellent infrastructure. The location of the Orth site near Vienna and directly on the border with Slovakia also facilitates cooperation with companies and skilled workers from across the CEE region, particularly from the Bratislava area and western Hungary.
How is INNEXIS in Austria harnessing the potential for research and growth?
INNEXIS is developing the Orth Pharma & Life Science Park, conveniently situated between Vienna and Bratislava, into an attractive location for innovative biotech and biopharmaceutical companies. The aim is to build a growing ecosystem comprising research, development, production and specialised services. In future, INNEXIS will also increasingly offer engineering and logistics solutions at the site to support companies across the entire value chain. The site is aimed in particular at companies that develop and produce modern therapies such as biologics, plasmid DNA, mRNA or cell and gene therapies. As many buildings have already been validated and prepared to meet regulatory requirements, companies can quickly commence operations and efficiently establish new production capacity. In the long term, this is intended to foster a dynamic life sciences ecosystem that promotes innovation and facilitates international collaboration.
Good to know!
The site in Orth an der Donau (Lower Austria) was established as a biomedical research centre back in 1982 and has developed over several decades into an internationally connected life sciences hub.
Around 7,000 specialists in research, development, production and technical services work at INNEXIS’s pharmaceutical and life science parks in Marburg, Jena and Orth.
How does ABA support international companies such as INNEXIS?
The Austrian Business Agency is Austria’s national business location agency and supports international companies with their market entry and expansion. It supports investors with comprehensive information on the business location, facilitates contacts with authorities, research institutions and regional partners, and advises on funding opportunities. Furthermore, INNEXIS works closely with ecoplus, the business agency of the Province of Lower Austria, which provides support through its regional location expertise and network within the Lower Austrian economy. Through international location marketing and trade fair appearances, the ABA also helps to raise the profile of Austria as an attractive life sciences location. For companies such as INNEXIS, this support facilitates access to the Austrian innovation ecosystem and helps to develop new partnerships with international pharmaceutical and biotech companies.
ABA Help Desk
Let's talk

Top Download Invest

- Top infrastructure & central location
- Stable framework conditions
- Supportive environment for innovation



